Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain

被引:19
作者
de Mulder, Miguel [1 ]
Yebra, Gonzalo [1 ]
Martin, Leticia [1 ]
Prieto, Luis [3 ]
Jose Mellado, Maria [2 ]
Rojo, Pablo [4 ]
Angeles Munoz-Fernandez, Maria [5 ]
Jimenez de Ory, Santiago [5 ]
Tomas Ramos, Jose [3 ]
Holguin, Africa [1 ]
机构
[1] Hosp Univ Ramon y Cajal, HIV Mol Epidemiol Lab 1, Dept Microbiol & Parasitol, FiBIO IRYCIS, Madrid 28034, Spain
[2] Hosp Univ Carlos III, Madrid, Spain
[3] Hosp Univ Getafe, Madrid, Spain
[4] Hosp Univ Doce Octubre, Madrid, Spain
[5] Hosp Gen Univ Gregorio Maranon, Madrid, Spain
关键词
HIV/AIDS; antiretroviral therapy; drug resistance; paediatrics; NON-B SUBTYPES; TO-CHILD-TRANSMISSION; ANTIRETROVIRAL THERAPY; UNITED-KINGDOM; INFECTION; MUTATION; STRAINS; IMPACT; RECOMMENDATIONS; SURVEILLANCE;
D O I
10.1093/jac/dkr305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Drug resistance mutations affect antiretroviral therapy (ART) effectiveness in HIV-1-infected children, compromising long-term therapy. HIV-1 variants and drug resistance mutations were identified in HIV-infected children from Madrid, Spain. Methods: Patients from the Madrid cohort of HIV-infected children (1993-2009) with available pol sequences or infected samples stored at the Spanish HIV-1 BioBank were selected. Specimens were used to perform new pol sequences when not available. HIV-1 variants were characterized by phylogenetic analysis. Resistance mutations were identified according to the International AIDS Society-USA list (2009). Results: In 198 patients, pol sequences were recovered from routine resistance testing (n=98) or newly performed using stored plasma, lymphocytes or DNA (n=100). Patients were mostly Europeans (90%), with moderate to severe AIDS symptoms (65%), on ART (85%) when the specimen was sequenced and infected by subtype B (90%). Among the 19 HIV-1 non-B variants found, 58% were recombinants (8CRF02_AG, 1CRF08_BC, 1CRF12_BF and 1CRF13_cpx) and the rest were 'pure' non-B subtypes (1A2, 2C, 2D, 1F1, 1G and 1H). Transmitted drug resistance (TDR) mutations were detected in 13% of naive children; 4%, 7% and 10% for protease inhibitors (PIs), nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), respectively. Global resistance prevalence was higher (66%) among ART-exposed children; 37% for PIs, 54% for NRTIs and 35% for NNRTIs. Conclusions: HIV-1 non-B variants infected 10% of the cohort during 1993-2009. Resistant viruses were present in 26.5% and 66% of naive and pretreated children, respectively. Our data suggest that TDR prevalence in children could be higher than that reported in adults in Spain. The provided data will help to improve clinical management of HIV-infected children in Spain.
引用
收藏
页码:2362 / 2371
页数:10
相关论文
共 43 条
[1]  
[Anonymous], REP GLOB AIDS EP
[2]  
[Anonymous], 2010, Towards universal access: scaling up priority HIV/AIDS interventions in the health sector
[3]   HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads [J].
Baeten, Jared M. ;
Chohan, Bhavna ;
Lavreys, Ludo ;
Chohan, Vrasha ;
McClelland, R. Scott ;
Certain, Laura ;
Mandaliya, Kishorchandra ;
Jaoko, Walter ;
Overbaugh, Julie .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (08) :1177-1180
[4]  
Bennett DE, 2008, ANTIVIR THER, V13, P25
[5]   Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update [J].
Bennett, Diane E. ;
Camacho, Ricardo J. ;
Otelea, Dan ;
Kuritzkes, Daniel R. ;
Fleury, Herve ;
Kiuchi, Mark ;
Heneine, Walid ;
Kantor, Rami ;
Jordan, Michael R. ;
Schapiro, Jonathan M. ;
Vandamme, Anne-Mieke ;
Sandstrom, Paul ;
Boucher, Charles A. B. ;
van de Vijver, David ;
Rhee, Soo-Yon ;
Liu, Tommy F. ;
Pillay, Deenan ;
Shafer, Robert W. .
PLOS ONE, 2009, 4 (03)
[6]   HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children [J].
Boivin, Michael J. ;
Ruel, Theodore D. ;
Boal, Hannah E. ;
Bangirana, Paul ;
Cao, Huyen ;
Eller, Leigh A. ;
Charlebois, Edwin ;
Havlir, Diane V. ;
Kamya, Moses R. ;
Achan, Jane ;
Akello, Carolyne ;
Wong, Joseph K. .
AIDS, 2010, 24 (08) :1163-1170
[7]   Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007 [J].
Brennan, Catherine A. ;
Yamaguchi, Julie ;
Devare, Sushil G. ;
Foster, Greg A. ;
Stramer, Susan L. .
TRANSFUSION, 2010, 50 (12) :2707-2712
[8]   HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004 [J].
Chakraborty, Rana ;
Smith, Colette J. ;
Dunn, David ;
Green, Hannah ;
Duong, Trinh ;
Doerholt, Kaya ;
Riordon, Andrew ;
Lyall, Hermione ;
Tookey, Pat ;
Butler, Karina ;
Sabin, Caroline A. ;
Gibb, Di ;
Pillay, Deenan .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (05) :457-459
[9]   Antiretroviral Resistance Patterns and HIV-1 Subtype in Mother-Infant Pairs after the Administration of Combination Short-Course Zidovudine plus Single-Dose Nevirapine for the Prevention of Mother-to-Child Transmission of HIV [J].
Chalermchockcharoenkit, Amphan ;
Culnane, Mary ;
Chotpitayasunondh, Tawee ;
Vanprapa, Nirun ;
Leelawiwat, Wanna ;
Mock, Philip A. ;
Asavapiriyanont, Suvanna ;
Teeraratkul, Achara ;
McConnell, Michelle S. ;
McNicholl, Janet M. ;
Tappero, Jordan W. .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (02) :299-305
[10]  
Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195